Jean-christophe C. Faivre

Vandoeuvre-les-nancy, FR 
Vandoeuvre-les-nancy, FR 

Overview

Jean-christophe Faivre practices practicing medicine in Vandoeuvre-les-nancy, France.

His clinical expertise encompasses Bone Tumor, Lung Metastases, Anal Cancer, Colostomy, and Hysterectomy.

He is actively involved in clinical research, co-authoring 126 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Vandoeuvre-les-nancy, France
Other Locations
Grenoble, France
Nancy, France
Dijon, France
54519, France
Metz, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Comparative Pilot Study Evaluating the Effectiveness of autoHYpnosis by Anchoring in the Prevention of Anxiety Related to Wearing the Mask for Radiotherapy of Head and Neck Tumors
Randomized, Comparative Pilot Study Evaluating the Effectiveness of autoHYpnosis by Anchoring in the Prevention of Anxiety Related to Wearing the Mask for Radiotherapy of Head and Neck Tumors
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Multicenter Prospective Phase II Study of Postoperative Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Early Stage Oropharyngeal and Oral Cavity Cancers With High Risk Margins.
A Multicenter Prospective Phase II Study of Postoperative Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Early Stage Oropharyngeal and Oral Cavity Cancers With High Risk Margins.
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

126 Total Publications

Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial.
Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial.
Journal: JAMA network open
Published: February 03, 2026

Frequently Asked Questions about Jean-christophe C. Faivre

Is Jean-christophe C. Faivre a top-rated expert for Bone Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-christophe C. Faivre is classified as an Experienced expert for Bone Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-christophe C. Faivre participate in research or clinical trials?

Yes. Jean-christophe C. Faivre has published 126 articles and abstracts on conditions like Bone Tumor. You can view a list of Jean-christophe C. Faivre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Faivre's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile